Paper11462016
Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors.
Crotty S and 9 others. J Virol, 2001. Cited by 82 papers, by iCite.
Cite this record
ConductScience Library. Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors. Papers, record 11462016. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11462016
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arenaviruses, New World | Major topic |
| Genetic Vectors | Major topic |
| Simian Acquired Immunodeficiency Syndrome | Major topic |
| Simian Immunodeficiency Virus | Major topic |
| Viral Vaccines | Major topic |
| Animals | |
| Female | |
| Humans | |
| Macaca | |
| Recombination, Genetic | |
| Vagina |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| N01-CO-56000 | NCI NIH HHS | United States | N01CO056000 | PubMed and NIH | NIH RePORTER |
| R56 AI036178 | NIAID NIH HHS | United States | R01AI036178 | PubMed and NIH | NIH RePORTER |
| R01 AI036178 | NIAID NIH HHS | United States | R01AI036178 | PubMed and NIH | NIH RePORTER |
| AI36178 | NIAID NIH HHS | United States | R01AI036178 | PubMed and NIH | NIH RePORTER |
| AI33434 | NIAID NIH HHS | United States | R01AI033434 | PubMed and NIH | NIH RePORTER |
| R21 AI036178 | NIAID NIH HHS | United States | R01AI036178 | PubMed and NIH | NIH RePORTER |
| R21AI036178 | NIH | NIH RePORTER | |||
| R56AI036178 | NIH | NIH RePORTER |
References69
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9653167 | Poliovirus vaccine vectors elicit antigen-specific cytotoxic T cells and protect mice against lethal challenge with malignant melanoma cells expressing a model antigen. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9653167 | PubMed |
| 2 | 10516057 | Mucosal immunization of cynomolgus macaques with two serotypes of live poliovirus vectors expressing simian immunodeficiency virus antigens: stimulation of humoral, mucosal, and cellular immunity. | J Virol | 1999 | https://conductscience.org/library/papers/10516057 | PubMed |
| 3 | 8416384 | Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection. | J Virol | 1993 | https://conductscience.org/library/papers/8416384 | PubMed |
| 4 | 2552175 | Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine. | J Virol | 1989 | https://conductscience.org/library/papers/2552175 | PubMed |
| 5 | 10812733 | It is too early to stop polio vaccination. | Bull World Health Organ | 2000 | https://conductscience.org/library/papers/10812733 | PubMed |
| 6 | 2839686 | Biological characterization of a simian immunodeficiency virus-like retrovirus (HTLV-IV): evidence for CD4-associated molecules required for infection. | J Virol | 1988 | https://conductscience.org/library/papers/2839686 | PubMed |
| 7 | 7884874 | A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous, cell-free simian immunodeficiency virus challenge. | J Virol | 1995 | https://conductscience.org/library/papers/7884874 | PubMed |
| 8 | 11100123 | The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. | Nat Med | 2000 | https://conductscience.org/library/papers/11100123 | PubMed |
| 9 | 8073288 | Engineering poliovirus as a vaccine vector for the expression of diverse antigens. | Science | 1994 | https://conductscience.org/library/papers/8073288 | PubMed |
| 10 | 10566147 | Cytotoxic T lymphocytes specific for the simian immunodeficiency virus. | Immunol Rev | 1999 | https://conductscience.org/library/papers/10566147 | PubMed |
| 11 | 8955203 | Neutralizing and infection-enhancing antibody responses do not correlate with the differential pathogenicity of SIVmac239delta3 in adult and infant rhesus monkeys. | J Immunol | 1996 | https://conductscience.org/library/papers/8955203 | PubMed |
| 12 | 7910329 | Paralytic poliomyelitis: seasoned strategies, disappearing disease. | Lancet | 1994 | https://conductscience.org/library/papers/7910329 | PubMed |
| 13 | 9933172 | Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. | Science | 1999 | https://conductscience.org/library/papers/9933172 | PubMed |
| 14 | 9311872 | Toward a poliovirus-based simian immunodeficiency virus vaccine: correlation between genetic stability and immunogenicity. | J Virol | 1997 | https://conductscience.org/library/papers/9311872 | PubMed |
| 15 | 10982366 | Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases. | J Virol | 2000 | https://conductscience.org/library/papers/10982366 | PubMed |
| 16 | 10973217 | Cytokine production in motor neurons by poliovirus replicon vector gene delivery. | Nat Biotechnol | 2000 | https://conductscience.org/library/papers/10973217 | PubMed |
| 17 | 10655111 | Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. | Nat Med | 2000 | https://conductscience.org/library/papers/10655111 | PubMed |
| 18 | 9273700 | The polio eradication effort: should vaccine eradication be next? | Science | 1997 | https://conductscience.org/library/papers/9273700 | PubMed |
| 19 | 10933680 | Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus. | J Virol | 2000 | https://conductscience.org/library/papers/10933680 | PubMed |
| 21 | 1939569 | Development of simian immunodeficiency virus isolation, titration, and neutralization assays which use whole blood from rhesus monkeys and an antigen capture enzyme-linked immunosorbent assay. | J Clin Microbiol | 1991 | https://conductscience.org/library/papers/1939569 | PubMed |
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 82 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34234789 | Oral Vaccination Approaches for Anti-SHIV Immunity. | Front Immunol | 2021 | https://conductscience.org/library/papers/34234789 | PubMed |
| 33328567 | Mucosal IL-4R antagonist HIV vaccination with SOSIP-gp140 booster can induce high-quality cytotoxic CD4+/CD8+ T cells and humoral responses in macaques. | Sci Rep | 2020 | https://conductscience.org/library/papers/33328567 | PubMed |
| 32962398 | Comparative Evaluation of Prophylactic SIV Vaccination Modalities Administered to the Oral Cavity. | AIDS Res Hum Retroviruses | 2020 | https://conductscience.org/library/papers/32962398 | PubMed |
| 31452652 | Mucosal Vaccine Approaches for Prevention of HIV and SIV Transmission. | Curr Immunol Rev | 2019 | https://conductscience.org/library/papers/31452652 | PubMed |
| 29540453 | Emergency Services of Viral RNAs: Repair and Remodeling. | Microbiol Mol Biol Rev | 2018 | https://conductscience.org/library/papers/29540453 | PubMed |
| 27853256 | Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses. | Sci Rep | 2016 | https://conductscience.org/library/papers/27853256 | PubMed |
| 26907330 | Therapeutic Use of Native and Recombinant Enteroviruses. | Viruses | 2016 | https://conductscience.org/library/papers/26907330 | PubMed |
| 26185576 | HIV/AIDS vaccines for Africa: scientific opportunities, challenges and strategies. | Pan Afr Med J | 2015 | https://conductscience.org/library/papers/26185576 | PubMed |
| 25196380 | Challenges in mucosal HIV vaccine development: lessons from non-human primate models. | Viruses | 2014 | https://conductscience.org/library/papers/25196380 | PubMed |
| 23963535 | Longitudinal analysis of intra-host simian immunodeficiency virus recombination in varied tissues of the rhesus macaque model for neuroAIDS. | J Gen Virol | 2013 | https://conductscience.org/library/papers/23963535 | PubMed |
| 23925000 | Development of replication-competent viral vectors for HIV vaccine delivery. | Curr Opin HIV AIDS | 2013 | https://conductscience.org/library/papers/23925000 | PubMed |
| 23392202 | CD34+ hematopoietic stem cells support entry and replication of poliovirus: a potential new gene introduction route. | Cancer Gene Ther | 2013 | https://conductscience.org/library/papers/23392202 | PubMed |
| 22464964 | Induction of mucosal HIV-specific B and T cell responses after oral immunization with live coxsackievirus B4 recombinants. | Vaccine | 2012 | https://conductscience.org/library/papers/22464964 | PubMed |
| 22031182 | Comparison of systemic and mucosal vaccination: impact on intravenous and rectal SIV challenge. | Mucosal Immunol | 2012 | https://conductscience.org/library/papers/22031182 | PubMed |
| 20824074 | Oral immunization with a live coxsackievirus/HIV recombinant induces gag p24-specific T cell responses. | PLoS One | 2010 | https://conductscience.org/library/papers/20824074 | PubMed |
| 19597003 | Obstacles to the successful development of an efficacious T cell-inducing HIV-1 vaccine. | J Leukoc Biol | 2009 | https://conductscience.org/library/papers/19597003 | PubMed |
| 19389440 | Packaging limits and stability of HIV-1 sequences in a coxsackievirus B vector. | Vaccine | 2009 | https://conductscience.org/library/papers/19389440 | PubMed |
| 18947849 | Systemic neutralizing antibodies induced by long interval mucosally primed systemically boosted immunization correlate with protection from mucosal SHIV challenge. | Virology | 2008 | https://conductscience.org/library/papers/18947849 | PubMed |
| 18272584 | Vaccine protection by live, attenuated simian immunodeficiency virus in the absence of high-titer antibody responses and high-frequency cellular immune responses measurable in the periphery. | J Virol | 2008 | https://conductscience.org/library/papers/18272584 | PubMed |
| 16731926 | Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239. | J Virol | 2006 | https://conductscience.org/library/papers/16731926 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11462016
GET https://conductscience.org/api/papers/v1/11462016/references?page=2